GENEWIZ WEEK 2024 WORKSHOP
Enhancing Gene Transfer Efficiency: Viral vs. Non-Viral Methods
![GWeek24_Workshops_LP-Laptop-Graphic@3x GWeek24_Workshops_LP-Laptop-Graphic@3x](https://web.genewiz.com/hs-fs/hubfs/2024-09%20GEN%20-%20GENEWIZ%20Week/2024-09%20GEN%20-%20GENEWIZ%20Week%20Workshops/GWeek24_Workshops_LP-Laptop-Graphic@3x.png?width=400&height=242&name=GWeek24_Workshops_LP-Laptop-Graphic@3x.png)
About the workshop
Innovations in transgene delivery are transforming biomedical research and therapeutic applications. Viral vectors, such as lentivirus and adeno-associated virus (AAV), are noted for their high efficiency and stable integration but pose risks such as immunogenicity and insertional mutagenesis. Non-viral methods, including lipid-based nanoparticles (LNPs) and CRISPR/Cas9-based delivery, offer safer alternatives with lower immunogenic risks. Discover the latest advancements in transgene introduction and cutting-edge techniques to enhance the efficacy of each approach.
What you'll learn about
- Various ways to introduce transgene cassettes in cells for downstream expression analysis
- Common risks associated with viral vectors and how to overcome them
- Enhancing your research capabilities through robust synthesis solutions
About the presenter
![PrassannaRao_500x500px](https://web.genewiz.com/hubfs/2024-09%20GEN%20-%20GENEWIZ%20Week/2024-09%20GEN%20-%20GENEWIZ%20Week%20Workshops/PrassannaRao_500x500px.png)
Prassanna Rao, Ph.D.
Technical Applications Scientist, Azenta Life Sciences
Dr. Prassanna Rao earned his Ph.D. in biological sciences from the Florida Institute of Technology, focusing on molecular microbiology. At Azenta, Dr. Rao supports business operations and is a subject matter expert for de novo synthesis and integrated solutions, dedicated to bridging the gap between scientific innovation and real-world applications.